Alpha Diallo
Impact in
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS Research and Interventions
- Hepatology top 1%
- Hepatitis C virus research
Papers in
-
- COVID-19 Clinical Research Studies 23
- HIV/AIDS drug development and treatment 11
- SARS-CoV-2 and COVID-19 Research 10
- HIV/AIDS Research and Interventions 6
- Hepatology 20
- Hepatitis C virus research 20
- Co-authors
- Lionel Piroth (1 shared paper)Gilles Hejblum (2 shared papers)François Bailly (1 shared paper)Laurence Meyer (1 shared paper)Céline Dorival (3 shared papers)François Téoulé (1 shared paper)Nathanaël Lapidus (3 shared papers)Clovis Lusivika‐Nzinga (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (8 papers)Journal of Hepatology (7 papers)Clinical Infectious Diseases (6 papers)The Lancet Infectious Diseases (6 papers)Scientific Reports (4 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Alpha Diallo
101 papers receiving 6.8k citations
Alpha Diallo's Hit Papers
Peers
Comparison fields: 5 of 121
- Infectious Diseases 3.9k
- Hepatology 768
- Immunology 1.4k
- Neurology 299
- Rheumatology 192
Countries citing papers authored by Alpha Diallo
This map shows the geographic impact of Alpha Diallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpha Diallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpha Diallo more than expected).
Fields of papers citing papers by Alpha Diallo
This network shows the impact of papers produced by Alpha Diallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpha Diallo. The network helps show where Alpha Diallo may publish in the future.
Co-authors
The 25 scholars most cited alongside Alpha Diallo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2107 |
| 2 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 1757 |
| 3 | Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study Hit paper breakdown → | 2019 | 500 |
| 4 | Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study Hit paper breakdown → | 2017 | 397 |
| 5 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 290 |
| 6 | 2021 | 258 | |
| 7 | 2022 | 145 | |
| 8 | 2020 | 129 | |
| 9 | 2015 | 102 | |
| 10 | 2016 | 97 | |
| 11 | 2021 | 93 | |
| 12 | 2021 | 75 | |
| 13 | 2023 | 63 | |
| 14 | 2022 | 58 | |
| 15 | 2019 | 57 | |
| 16 | 2020 | 55 | |
| 17 | 2020 | 53 | |
| 18 | 2022 | 52 | |
| 19 | 2023 | 36 | |
| 20 | 2015 | 32 |
About Alpha Diallo
Alpha Diallo is a scholar working on Infectious Diseases, Hepatology, Virology, Toxicology and Neurology, having authored 105 papers that have together received 7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (23 papers), Hepatitis C virus research (20 papers), HIV/AIDS drug development and treatment (11 papers), SARS-CoV-2 and COVID-19 Research (10 papers), HIV/AIDS Research and Interventions (6 papers), Poxvirus research and outbreaks (6 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Long-Term Effects of COVID-19 (5 papers). The work is most often cited by research in Infectious Diseases (3.9k citations), Hepatology (768 citations), Immunology (1.4k citations), Neurology (299 citations) and Rheumatology (192 citations). Alpha Diallo has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Lionel Piroth, Gilles Hejblum, François Bailly, Laurence Meyer, Céline Dorival, François Téoulé, Nathanaël Lapidus, Clovis Lusivika‐Nzinga, Mélanie Simony and Stanislas Pol. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Hepatology, Clinical Infectious Diseases, The Lancet Infectious Diseases and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.